Journal of Health Sciences & Surveillance System

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Systematic Review and Meta-analysis of Depression and Anxiety in the Middle East during the Covid-19 Pandemic

Document Type : Review Articles

Authors

1 Social Determinants of Health Research Center, Research Institute for Prevention of Non Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran

2 Student Research Committee, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran

3 Student Research Committee, Faculty of Health Management and Information Sciences Branch, Iran University of Medical Sciences, Tehran, Iran

4 Department of Health Care Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran

5 Clinical Research and Development Center, Qom University of Medical Sciences, Qazvin, Iran

6 Bone and Joint Reconstruction Research Center, Department of Orthopedics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

7 Social Determinants of the Health Research Center, Qazvin University of Medical Sciences, Qazvin, Iran

8 Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran

9 Researcher at Toward Evidence (Affiliztion)

10 The School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, UK

Abstract

Background: Depression and anxiety are the psychological problems that have intensified during Covid-19 and have affected the psychological well being of people. The purpose of this study was to systematically review the prevalence of anxiety and depression in Middle East countries.
Methods: In this review, we searched for studies aiming to estimate the prevalence of depression and anxiety during the Covid-19 pandemic among the general population in databases including Scopus, PubMed, Web of Science, EMBASE, and Google Scholar from January 2020 to February 2021. We used the Comprehensive Meta-Analysis-2 software for data analyses and generated forest plots of the summary pooled prevalence.
Results: In this systematic review, 55 articles with a total sample size of 28128 people were included. The pooled analysis of depression and anxiety amid the pandemic was estimated at 41% and 39%, respectively. Based on the study results, Iraq and Egypt had the highest prevalence rates of depression at 88% and 82%, respectively. Regarding anxiety, the highest and lowest prevalence rates were reported for Egypt with 91% and Qatar with 17%.
Conclusion: To effectively provide mental health services for people, particularly the ones who are suspected of higher risk of depression and anxiety, it is necessary to identify individuals who are more likely to be suffered from psychological problems.

Keywords

References
  1. Raoofi S, Pashazadeh Kan F, Rafiei S, Khani S, Hosseinifard H, Tajik F, et al. Anxiety during the COVID-19 pandemic in hospital staff: systematic review plus meta-analysis. BMJ Support Palliat Care. 2021 Jul 26:bmjspcare-2021-003125. doi: 10.1136/bmjspcare-2021-003125. PMID: 34312187.
  2. Esmaeili Vardanjani A, Ronco C, Rafiei H, Golitaleb M, Pishvaei MH, Mohammadi M. Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19. Blood Purif. 2021;50(2):257-260. doi: 10.1159/000509107. PMID: 32594085; PMCID: PMC7360504.
  3. Mallet J, Dubertret C, Le Strat Y. Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110070. doi: 10.1016/j.pnpbp.2020.110070. PMID: 32800868; PMCID: PMC7420609.
  4. Skalski S, Uram P, Dobrakowski P, Kwiatkowska A. Thinking too much about the novel coronavirus. The link between persistent thinking about COVID-19, SARS-CoV-2 anxiety and trauma effects. Current Issues in Personality Psychology. 2020 Jan 1;8(3):169-74.
  5. Pfefferbaum B, North CS. Mental health and the Covid-19 pandemic. New England Journal of Medicine. 2020 Aug 6;383(6):510-2.
  6. Stojanov J, Stankovic M, Zikic O, Stankovic M, Stojanov A. The risk for nonpsychotic postpartum mood and anxiety disorders during the COVID-19 pandemic. Int J Psychiatry Med. 2021 Jul;56(4):228-239. doi: 10.1177/0091217420981533. PMID: 33322982; PMCID: PMC8191144.
  7. Cheng P, Xia G, Pang P, Wu B, Jiang W, Li YT, et al. COVID-19 Epidemic Peer Support and Crisis Intervention Via Social Media. Community Ment Health J. 2020 Jul;56(5):786-792. doi: 10.1007/s10597-020-00624-5. PMID: 32378126; PMCID: PMC7202462.
  8. Zhang SX, Sun S, Afshar Jahanshahi A, Alvarez-Risco A, Ibarra VG, Li J, et al. Developing and testing a measure of COVID-19 organizational support of healthcare workers - results from Peru, Ecuador, and Bolivia. Psychiatry Res. 2020 Sep;291:113174. doi: 10.1016/j.psychres.2020.113174.PMID: 32585436; PMCID: PMC7284268.
  9. Kan, F.P., et al., A systematic review of the prevalence of anxiety among the general population during the COVID-19 pandemic. Journal of Affective Disorders, 2021.
  10. Pashazadeh Kan F, Raoofi S, Rafiei S, Khani S, Hosseinifard H, Tajik F, et al. A systematic review of the prevalence of anxiety among the general population during the COVID-19 pandemic. J Affect Disord. 2021 Oct 1;293:391-398. doi: 10.1016/j.jad.2021.06.073. PMID: 34246947; PMCID: PMC8712560.
  11. Santomauro DF, Herrera AM, Shadid J, Zheng P, Ashbaugh C, Pigott DM, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet. 2021 Nov 6;398(10312):1700-12.
  12. Bas-Hoogendam JM, Groenewold NA, Aghajani M, Freitag GF, Harrewijn A, Hilbert K, et al. ENIGMA-anxiety working group: Rationale for and organization of large-scale neuroimaging studies of anxiety disorders. Hum Brain Mapp. 2022 Jan;43(1):83-112. doi: 10.1002/hbm.25100. PMID: 32618421; PMCID: PMC8805695.
  13. Strawn JR, Lu L, Peris TS, Levine A, Walkup JT. Research Review: Pediatric anxiety disorders - what have we learnt in the last 10 years? J Child Psychol Psychiatry. 2021 Feb;62(2):114-139. doi: 10.1111/jcpp.13262. PMID: 32500537; PMCID: PMC7718323.
  14. Ter Meulen WG, Draisma S, van Hemert AM, Schoevers RA, Kupka RW, Beekman ATF, et al. Depressive and anxiety disorders in concert-A synthesis of findings on comorbidity in the NESDA study. J Affect Disord. 2021 Apr 1;284:85-97. doi: 10.1016/j.jad.2021.02.004. PMID: 33588240.
  15. Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res. 2020 Jun;288:112954. doi: 10.1016/j.psychres.2020.112954. PMID: 32325383; PMCID: PMC7152913.
  16. Qiu J, Shen B, Zhao M, Wang Z, Xie B, Xu Y. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations. Gen Psychiatr. 2020 Mar 6;33(2):e100213. doi: 10.1136/gpsych-2020-100213. Erratum in: Gen Psychiatr. 2020 Apr 27;33(2):e100213corr1. PMID: 32215365; PMCID: PMC7061893.
  17. Uvais NA, Nalakath MJ, Shihabudheen P, Hafi NAB, Salman CA. Depression, Anxiety, and Coping During the COVID-19 Pandemic Among Indian Expats in the Middle East: A Survey Study. Prim Care Companion CNS Disord. 2021 Jan 21;23(1):20m02761. doi: 10.4088/PCC.20m02761. PMID: 33480484.
  18. Razzak HA, Harbi A, Ahli S. Depression: Prevalence and Associated Risk Factors in the United Arab Emirates. Oman Med J. 2019 Jul;34(4):274-282. doi: 10.5001/omj.2019.56. PMID: 31360314; PMCID: PMC6642715.
  19. Rajkumar RP. COVID-19 and mental health: A review of the existing literature. Asian J Psychiatr. 2020 Aug;52:102066. doi: 10.1016/j.ajp.2020.102066. PMID: 32302935; PMCID: PMC7151415.
  20. Salari N, Hosseinian-Far A, Jalali R, Vaisi-Raygani A, Rasoulpoor S, Mohammadi M, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Global Health. 2020 Jul 6;16(1):57. doi: 10.1186/s12992-020-00589-w. PMID: 32631403; PMCID: PMC7338126.
  21. Ren X, Huang W, Pan H, Huang T, Wang X, Ma Y. Mental Health During the Covid-19 Outbreak in China: a Meta-Analysis. Psychiatr Q. 2020 Dec;91(4):1033-1045. doi: 10.1007/s11126-020-09796-5. PMID: 32642822; PMCID: PMC7343383.
  22. Newnham EA, Dzidic PL, Mergelsberg ELP, Guragain B, Chan EYY, Kim Y, e. The Asia Pacific Disaster Mental Health Network: Setting a Mental Health Agenda for the Region. Int J Environ Res Public Health. 2020 Aug 24;17(17):6144. doi: 10.3390/ijerph17176144. PMID: 32847057; PMCID: PMC7504085.
  23. Kayano R, Chan EY, Murray V, Abrahams J, Barber SL. WHO Thematic Platform for Health Emergency and Disaster Risk Management Research Network (TPRN): Report of the Kobe Expert Meeting. Int J Environ Res Public Health. 2019 Apr 6;16(7):1232. doi: 10.3390/ijerph16071232. PMID: 30959880; PMCID: PMC6480684.
  24. Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015 Feb;8(1):2-10. doi: 10.1111/jebm.12141. PMID: 25594108.
  25. Veronese N, Cereda E, Solmi M, Fowler SA, Manzato E, Maggi S, et al. Inverse relationship between body mass index and mortality in older nursing home residents: a meta-analysis of 19,538 elderly subjects. Obes Rev. 2015 Nov;16(11):1001-15. doi: 10.1111/obr.12309. PMID: 26252230.
  26. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71. PMID: 33782057; PMCID: PMC8005924.
  27. Liu D, Ren Y, Yan F, Li Y, Xu X, Yu X, et al. Psychological impact and predisposing factors of the coronavirus disease 2019 (COVID-19) pandemic on general public in China. 2020.
  28. World Health Organization. Mental health and psychosocial considerations during the COVID-19 outbreak, 18 March 2020, 2020, World Health Organization.
  29. Moghanibashi-Mansourieh A. Assessing the anxiety level of Iranian general population during COVID-19 outbreak. Asian J Psychiatr. 2020 Jun;51:102076. doi: 10.1016/j.ajp.2020.102076. PMID: 32334409; PMCID: PMC7165107.
  30. Ahmed MZ, Ahmed O, Aibao Z, Hanbin S, Siyu L, Ahmad A. Epidemic of COVID-19 in China and associated Psychological Problems. Asian J Psychiatr. 2020 Jun;51:102092. doi: 10.1016/j.ajp.2020.102092. PMID: 32315963; PMCID: PMC7194662.
  31. Zhou SJ, Zhang LG, Wang LL, Guo ZC, Wang JQ, Chen JC, et al. Prevalence and socio-demographic correlates of psychological health problems in Chinese adolescents during the outbreak of COVID-19. Eur Child Adolesc Psychiatry. 2020 Jun;29(6):749-758. doi: 10.1007/s00787-020-01541-4. PMID: 32363492; PMCID: PMC7196181.
  32. Cao W, Fang Z, Hou G, Han M, Xu X, Dong J, et al. The psychological impact of the COVID-19 epidemic on college students in China. Psychiatry Res. 2020 May;287:112934. doi: 10.1016/j.psychres.2020.112934. PMID: 32229390; PMCID: PMC7102633.
  33. Ueda M, Stickley A, Sueki H, Matsubayashi T. Mental health status of the general population during the COVID-19 pandemic: a cross-sectional national survey in Japan. MedRxiv. 2020 Jan 1.
  34. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS; National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003 Jun 18;289(23):3095-105. doi: 10.1001/jama.289.23.3095. PMID: 12813115.
  35. Johansson R, Carlbring P, Heedman Å, Paxling B, Andersson G. Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life. PeerJ. 2013 Jul 9;1:e98. doi: 10.7717/peerj.98. PMID: 23862109; PMCID: PMC3709104.
  36. Walker RJ, Campbell JA, Dawson AZ, Egede LE. Prevalence of psychological distress, depression and suicidal ideation in an indigenous population in Panamá. Soc Psychiatry Psychiatr Epidemiol. 2019 Oct;54(10):1199-1207. doi: 10.1007/s00127-019-01719-5. PMID: 31055631; PMCID: PMC6790172.
  37. Qian M, Wu Q, Wu P, Hou Z, Liang Y, Cowling BJ, et al. Psychological responses, behavioral changes and public perceptions during the early phase of the COVID-19 outbreak in China: a population based cross-sectional survey. MedRxiv. 2020 Jan 1.
  38. Martini J, Petzoldt J, Einsle F, Beesdo-Baum K, Höfler M, Wittchen HU. Risk factors and course patterns of anxiety and depressive disorders during pregnancy and after delivery: a prospective-longitudinal study. J Affect Disord. 2015 Apr 1;175:385-95. doi: 10.1016/j.jad.2015.01.012. EPMID: 25678171.
  39. Hou F, Bi F, Jiao R, Luo D, Song K. Gender differences of depression and anxiety among social media users during the COVID-19 outbreak in China:a cross-sectional study. BMC Public Health. 2020 Nov 4;20(1):1648. doi: 10.1186/s12889-020-09738-7. PMID: 33148202; PMCID: PMC7609822.
  40. Li X, Dai T, Wang H, Shi J, Yuan W, Li J, et al. [Clinical analysis of suspected COVID-19 patients with anxiety and depression]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):203-208. Chinese. doi: 10.3785/j.issn.1008-9292.2020.03.02. PMID: 32391665; PMCID: PMC8800785.
  41. Allwood L, Bell A. Covid-19: understanding inequalities in mental health during the pandemic. Centre for Mental Health. 2020 Jun;18.
  42. Elovainio M, Hakulinen C, Pulkki-Råback L, Virtanen M, Josefsson K, Jokela M, et al. Contribution of risk factors to excess mortality in isolated and lonely individuals: an analysis of data from the UK Biobank cohort study. Lancet Public Health. 2017 May 4;2(6):e260-e266. doi: 10.1016/S2468-2667(17)30075-0. PMID: 28626828; PMCID: PMC5463031.
  43. Hansson M, Chotai J, Nordstöm A, Bodlund O. Comparison of two self-rating scales to detect depression: HADS and PHQ-9. Br J Gen Pract. 2009 Sep;59(566):e283-8. doi: 10.3399/bjgp09X454070. PMID: 19761655; PMCID: PMC2734374.
  44. Olssøn I, Mykletun A, Dahl AA. The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005 Dec 14;5:46. doi: 10.1186/1471-244X-5-46. PMID: 16351733; PMCID: PMC1343544.
  45. Johnson SU, Ulvenes PG, Øktedalen T, Hoffart A. Psychometric Properties of the General Anxiety Disorder 7-Item (GAD-7) Scale in a Heterogeneous Psychiatric Sample. Front Psychol. 2019 Aug 6;10:1713. doi: 10.3389/fpsyg.2019.01713. PMID: 31447721; PMCID: PMC6691128.
Journal of Health Sciences & Surveillance System
Volume 11, 1 (Supplement)
January 2023
Pages 116-125
Files
Share
How to cite
Statistics